124 related articles for article (PubMed ID: 33947572)
1. Nano-encapsulation of hydroxytyrosol into formulated nanogels improves therapeutic effects against hepatic steatosis: An in vitro study.
Mauri E; Gori M; Giannitelli SM; Zancla A; Mozetic P; Abbruzzese F; Merendino N; Gigli G; Rossi F; Trombetta M; Rainer A
Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112080. PubMed ID: 33947572
[TBL] [Abstract][Full Text] [Related]
2. The Antioxidant Effects of Hydroxytyrosol and Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease, in a Clinical Trial: A New Treatment?
Nobili V; Alisi A; Mosca A; Crudele A; Zaffina S; Denaro M; Smeriglio A; Trombetta D
Antioxid Redox Signal; 2019 Jul; 31(2):127-133. PubMed ID: 30588836
[TBL] [Abstract][Full Text] [Related]
3. Quercetin and hydroxytyrosol as modulators of hepatic steatosis: A NAFLD-on-a-chip study.
Gori M; Giannitelli SM; Zancla A; Mozetic P; Trombetta M; Merendino N; Rainer A
Biotechnol Bioeng; 2021 Jan; 118(1):142-152. PubMed ID: 32889748
[TBL] [Abstract][Full Text] [Related]
4. Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD.
Pirozzi C; Lama A; Simeoli R; Paciello O; Pagano TB; Mollica MP; Di Guida F; Russo R; Magliocca S; Canani RB; Raso GM; Calignano A; Meli R
J Nutr Biochem; 2016 Apr; 30():108-15. PubMed ID: 27012627
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT.
Echeverría F; Valenzuela R; Bustamante A; Álvarez D; Ortiz M; Soto-Alarcon SA; Muñoz P; Corbari A; Videla LA
Oxid Med Cell Longev; 2018; 2018():5109503. PubMed ID: 30057681
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic acid and hydroxytyrosol co-administration fully prevents liver steatosis and related parameters in mice subjected to high-fat diet: A molecular approach.
Soto-Alarcón SA; Ortiz M; Orellana P; Echeverría F; Bustamante A; Espinosa A; Illesca P; Gonzalez-Mañán D; Valenzuela R; Videla LA
Biofactors; 2019 Nov; 45(6):930-943. PubMed ID: 31454114
[TBL] [Abstract][Full Text] [Related]
7. Hydroxytyrosol ameliorates insulin resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-induced obesity mice.
Wang N; Liu Y; Ma Y; Wen D
J Nutr Biochem; 2018 Jul; 57():180-188. PubMed ID: 29747118
[TBL] [Abstract][Full Text] [Related]
8. Hydroxytyrosol prevents reduction in liver activity of Δ-5 and Δ-6 desaturases, oxidative stress, and depletion in long chain polyunsaturated fatty acid content in different tissues of high-fat diet fed mice.
Valenzuela R; Echeverria F; Ortiz M; Rincón-Cervera MÁ; Espinosa A; Hernandez-Rodas MC; Illesca P; Valenzuela A; Videla LA
Lipids Health Dis; 2017 Apr; 16(1):64. PubMed ID: 28395666
[TBL] [Abstract][Full Text] [Related]
9. Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation.
Valenzuela R; Illesca P; Echeverría F; Espinosa A; Rincón-Cervera MÁ; Ortiz M; Hernandez-Rodas MC; Valenzuela A; Videla LA
Food Funct; 2017 Apr; 8(4):1526-1537. PubMed ID: 28386616
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant activity of Hydroxytyrosol and Vitamin E reduces systemic inflammation in children with paediatric NAFLD.
Mosca A; Crudele A; Smeriglio A; Braghini MR; Panera N; Comparcola D; Alterio A; Sartorelli MR; Tozzi G; Raponi M; Trombetta D; Alisi A
Dig Liver Dis; 2021 Sep; 53(9):1154-1158. PubMed ID: 33060043
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of hydroxytyrosol on liver ischemia/reperfusion injury in mice.
Pan S; Liu L; Pan H; Ma Y; Wang D; Kang K; Wang J; Sun B; Sun X; Jiang H
Mol Nutr Food Res; 2013 Jul; 57(7):1218-27. PubMed ID: 23650136
[TBL] [Abstract][Full Text] [Related]
12. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
[TBL] [Abstract][Full Text] [Related]
13. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
14. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
[TBL] [Abstract][Full Text] [Related]
15. Cross-linked polymeric nanogel formulations of 5'-triphosphates of nucleoside analogues: role of the cellular membrane in drug release.
Vinogradov SV; Kohli E; Zeman AD
Mol Pharm; 2005; 2(6):449-61. PubMed ID: 16323952
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
Vinogradov SV; Kohli E; Zeman AD
Pharm Res; 2006 May; 23(5):920-30. PubMed ID: 16715382
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-based polymer hybrids for thermo-responsive nanogel delivery of curcumin.
Luckanagul JA; Pitakchatwong C; Ratnatilaka Na Bhuket P; Muangnoi C; Rojsitthisak P; Chirachanchai S; Wang Q; Rojsitthisak P
Carbohydr Polym; 2018 Feb; 181():1119-1127. PubMed ID: 29253940
[TBL] [Abstract][Full Text] [Related]
18. Alteration in the liver metabolome of rats with metabolic syndrome after treatment with Hydroxytyrosol. A Mass Spectrometry And Nuclear Magnetic Resonance - based metabolomics study.
Dagla I; Benaki D; Baira E; Lemonakis N; Poudyal H; Brown L; Tsarbopoulos A; Skaltsounis AL; Mikros E; Gikas E
Talanta; 2018 Feb; 178():246-257. PubMed ID: 29136819
[TBL] [Abstract][Full Text] [Related]
19. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
20. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
